Truist Securities Maintains Buy on Verastem, Lowers Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Buy rating on Verastem (NASDAQ:VSTM) but lowered the price target from $18 to $15.
August 13, 2024 | 2:21 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities has maintained a Buy rating on Verastem but lowered the price target from $18 to $15.
The Buy rating suggests continued confidence in Verastem's potential, but the lowered price target indicates some tempered expectations. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100